Concurrent bevacizumab and temozolomide alter the patterns of failure in radiation treatment of glioblastoma multiforme

BACKGROUND: We investigated the pattern of failure in glioblastoma multiforma (GBM) patients treated with concurrent radiation, bevacizumab (BEV), and temozolomide (TMZ). Previous studies demonstrated a predominantly in-field pattern of failure for GBM patients not treated with concurrent BEV. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Shields, Lisa BE, Kadner, Robert, Vitaz, Todd W, Spalding, Aaron C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3648458/
https://www.ncbi.nlm.nih.gov/pubmed/23618500
http://dx.doi.org/10.1186/1748-717X-8-101

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3648458/
https://www.ncbi.nlm.nih.gov/pubmed/23618500
http://dx.doi.org/10.1186/1748-717X-8-101

Ejemplares similares